Outset Medical (OM) EBITDA Margin Growth (1y) (2020 - 2026)
Outset Medical (OM) EBITDA Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -430.00 |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 128.00 |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 301.00 |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 141.00 |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 102.00 |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 851.00 |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -313.00 |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 241.00 |
| 10 | Outset Medical | 80,106.28 | -286.56 Mn | 12.10 Mn | -560.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -560.00 |
| Dec 31, 2025 | 1,313.00 |
| Sep 30, 2025 | 2,943.00 |
| Jun 30, 2025 | 5,865.00 |
| Mar 31, 2025 | 7,592.00 |
| Dec 31, 2024 | 4,826.00 |
| Sep 30, 2024 | 6,655.00 |
| Jun 30, 2024 | 831.00 |
| Mar 31, 2024 | -111.00 |
| Dec 31, 2023 | 198.00 |
| Sep 30, 2023 | -202.00 |
| Jun 30, 2023 | 5,385.00 |
| Mar 31, 2023 | -1,054.00 |
| Dec 31, 2022 | 2,050.00 |
| Sep 30, 2022 | -3,317.00 |
| Jun 30, 2022 | -5,589.00 |
| Mar 31, 2022 | 1,010.00 |
| Dec 31, 2021 | 3,838.00 |
| Sep 30, 2021 | 18,160.00 |
| Jun 30, 2021 | 9,354.00 |